With No Increase in MI Risk Found, Some Avandia Restrictions Lifted (FREE)

By Amy Orciari Herman Certain restrictions on the diabetes drug rosiglitazone (Avandia) are being removed because a new analysis from the RECORD trial has found no increase in myocardial infarction risk — a risk first suggested by a 2007 meta-analysis.In 2010, the FDA ruled …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news